Patients with intracerebral aneurysm will be screened for sleep apnea using out of center polysomnography/polygraphy. Baseline blood pressure and medication will be assessed. Patients will be followed for up to 5 years to examine the increase in aneurysm size, rupture rate and changes in medication.
Patient presenting to the outpatient center for neurological of neurosurgical management of intracerebral aneurysm will be recruited. Sleep apnea will be assessed by questionnaire and out of center polygraph/polysomnography. Medication, comorbidities and blood pressure will be recorded. Change in aneurysm size and blood pressure medication will be evaluated annually for up to 5 years. Frequency of subarachnoid hemorrhage and increase in aneurysm size will be assessed.
Study Type
OBSERVATIONAL
Enrollment
200
Sleep apnea screening by out-of-center polysomnography/polygraphy
Department of Neurology and Department of Neurosurgery
Bonn, Germany
RECRUITINGBlood pressure medication
Blood pressure medication at baseline will be accessed.
Time frame: Baseline
Blood pressure
Blood pressure on baseline visit will be accessed.
Time frame: Baseline
Subarachnoid hemorrhage
Rate of aneurysm rupture and subarachnoid hemorrhage will be accessed annually.
Time frame: 5 years
Increase in size of aneurysm
Time frame: 5 years
Change in blood pressure medication
Blood pressure medication will be accessed on annual follow-up for up to 5 years.
Time frame: 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.